Valuation: Virbac

Market Cap 2.61B 2.94B 2.44B 2.22B 4.19B 283B 4.25B 29.54B 11.43B 144B 11.04B 10.8B 463B P/E 2026 *
15.1x
P/E 2027 * 13.6x
Enterprise Value 2.73B 3.08B 2.56B 2.33B 4.39B 296B 4.45B 30.92B 11.97B 151B 11.55B 11.3B 485B EV / Sales 2026 *
1.77x
EV / Sales 2027 * 1.62x
Free-Float
49.03%
Yield 2026 *
0.55%
Yield 2027 * 0.66%
1 day-1.61%
1 week+1.49%
Current month-1.61%
1 month-4.96%
3 months-7.12%
6 months-13.42%
Current year-14.27%
1 week 301
Extreme 301
316
1 month 297
Extreme 297
324
Current year 297
Extreme 297
389.5
1 year 297
Extreme 297
389.5
3 years 249.7
Extreme 249.7
400
5 years 215
Extreme 215
448.5
10 years 102.1
Extreme 102.1
448.5
Manager TitleAgeSince
Chief Executive Officer 46 01/09/2025
Chief Executive Officer 50 27/09/2024
Chief Operating Officer 64 01/01/2022
Director TitleAgeSince
Chairman 61 01/04/2006
Director/Board Member 68 28/07/2010
Director/Board Member 65 05/09/2017
Date Insider Type Main position Quantity % Market Cap. Importance
22/04/24 Sell

Chief Executive Officer

810 0.0096%
22/04/24 Sell

Chief Executive Officer

140 0.0017%
22/04/24 Sell

Chief Executive Officer

1,688 0.0200%
Change 5-day change 1-year change 3-year change Capi.($)
-1.61%+1.49%-3.77%+17.88% 2.96B
-0.76%-2.94%+38.98%+113.11% 1,031B
-1.99%-4.03%+39.62%+67.43% 638B
-0.68%-2.12%+6.19%+75.04% 462B
-0.81%-2.64%+59.86%+40.50% 359B
-0.03%-3.96%+23.63%+40.70% 335B
-1.58%-0.76%+13.50%+26.44% 273B
-2.02%-2.97%-3.25%+9.88% 253B
-2.49%+0.83%+37.16%+53.73% 228B
-0.68%-1.30%+32.92%+99.39% 185B
Average -1.29%-0.10%+24.48%+54.41% 376.68B
Weighted average by Cap. -1.16%-0.34%+30.56%+69.79%

Financials

2026 *2027 *
Net sales 1.55B 1.74B 1.45B 1.32B 2.48B 168B 2.52B 17.5B 6.78B 85.42B 6.54B 6.4B 274B 1.64B 1.85B 1.54B 1.4B 2.64B 178B 2.67B 18.6B 7.2B 90.77B 6.95B 6.8B 292B
Net income 174M 196M 163M 148M 279M 18.85B 283M 1.97B 762M 9.6B 735M 719M 30.84B 194M 218M 181M 165M 311M 21B 315M 2.19B 848M 10.7B 819M 801M 34.35B
Net Debt 122M 138M 114M 104M 196M 13.27B 199M 1.38B 536M 6.76B 517M 506M 21.7B 44.72M 50.35M 41.82M 38.11M 71.75M 4.85B 72.73M 506M 196M 2.47B 189M 185M 7.93B
Logo Virbac
Virbac specializes in the research, production and marketing of veterinary medicines. Net sales break down by family of products as follows: - pet medications (60.7%): pest control drugs, vaccines, antibiotics, anesthetics, anti-inflammatory drugs, mouth/dental care products, ophthalmologic and dermatological products intended for dogs, cats, horses, birds, rodents, etc. The group also offers foods and electronic identification chips; - livestock medications (39.3%): pest control drugs and antibiotics intended for cattle, sheep, pigs, poultry, etc. Net sales are distributed geographically as follows: Europe (41.6%), Latin America (15.2%), North America (13.6%), India/Africa/Middle East (12.2%), Eastern Asia (10.5%) and Pacific (6.9%).
Employees
6,442
Date Price Change Volume
01/10/26 €306.50 -1.61% 11,691
30/09/26 €311.50 +0.32% 20,087
29/09/26 €310.50 +0.98% 3,503
28/09/26 €307.50 +1.32% 5,029
25/09/26 €303.50 +0.50% 4,384
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
8
Last Close Price
311.50EUR
Average target price
412.75EUR
Spread / Average Target
+32.50%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. VIRP Stock